SOLVED

Question
Answered
Asked by ChancellorHeatRedPanda27
The PMHNP conducts pharmacogenomic testing for a 22 year-old Caucasian female who is a poor CYP450 2D6 metabolizer. The patient is diagnosed with Major Depressive Disorder, Current episode unspecified. She has been taking Venlafaxine for one year, is medication adherent, and reports partial remission of dysphoria on max dose without side effects. Which of the following medications could be considered as an alternative due to its chemical similarity? a. Pristiq b. Cymbalta c. Paxil d. Fluvox
SCIENCE
HEALTH SCIENCE
NURSING

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."